Salarius Pharmaceuticals (SLRX) Insider Trading & Ownership $1.34 -0.04 (-2.90%) (As of 11/15/2024 08:55 PM ET) Add Compare Share Share Insider Trades Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Salarius Pharmaceuticals (NASDAQ:SLRX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage1.38%Number OfInsiders Buying(Last 3 Years)4Amount OfInsider Buying(Last 3 Years)$19,084.88Number OfInsiders Selling(Last 3 Years)0 Get SLRX Insider Trade Alerts Want to know when executives and insiders are buying or selling Salarius Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address SLRX Insider Buying and Selling by Quarter Ad Priority GoldJD Vance Predicts: Wall Street vs. Trump & Your MoneyTrump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.Get your free guide NOW before it's too late. Salarius Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails6/6/2022William K McvicarDirectorBuy3,319$1.52$5,044.88 6/3/2022Arnold C HanishDirectorBuy3,500$1.44$5,040.00 5/31/2022Mark J RosenblumCFOBuy3,500$1.44$5,040.00 5/26/2022David J ArthurCEOBuy2,750$1.44$3,960.00 (Data available from 1/1/2013 forward) SLRX Insider Trading Activity - Frequently Asked Questions Who is on Salarius Pharmaceuticals's Insider Roster? The list of insiders at Salarius Pharmaceuticals includes Arnold C Hanish, David J Arthur, Mark J Rosenblum, and William K Mcvicar. Learn more on insiders at SLRX. What percentage of Salarius Pharmaceuticals stock is owned by insiders? 1.38% of Salarius Pharmaceuticals stock is owned by insiders. Learn more on SLRX's insider holdings. Salarius Pharmaceuticals Key ExecutivesMr. David J. Arthur M.B.A. (Age 61)CEO, President & Director Compensation: $343.2kMr. Mark J. Rosenblum CPA (Age 71)Executive VP of Finance & CFO More Insider Trading Tools from MarketBeat Related Companies RNAZ Insider Buying EDSA Insider Buying SNGX Insider Buying COEP Insider Buying VIRX Insider Buying GLTO Insider Buying UPXI Insider Buying CYCN Insider Buying ONVO Insider Buying MBRX Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking OnInsiders Are Buying High-Yielding Delek Logistics Partners This page (NASDAQ:SLRX) was last updated on 11/18/2024 by MarketBeat.com Staff From Our Partners“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredJD Vance Predicts: Wall Street vs. Trump & Your MoneyTrump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purpose...Priority Gold | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredFREE investing Class TOMORROW + 2 FREE BonusesOver the last 37 years on Wall Street, I've developed a unique investing strategy that allows me to find stock...Unstoppable Prosperity | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | SponsoredTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will ...Weiss Ratings | SponsoredUS Debt Breaks Records and Threatens Dollar Ahead of ElectionNeed to Rescue Your Retirement in 2024? Help Prevent Inflation from Flushing Your Hard Work Down the DrainPreserve Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Salarius Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Salarius Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
